subscribe
 

GE Healthcare launches new software to expand Biacore T200’s capabilities for highly sensitive, focused screening

12th June 2013


Biacore™* T200 Software v.2.0 enhances the capabilities of Biacore T200, offering researchers a flexible and powerful tool for efficient processing of molecular interaction data.

Together, they facilitate label-free screening of low molecular weight compounds and low abundance proteins, giving detailed binding profiles on molecule-drug candidate mechanisms of action that ultimately assist in earlier lead selection and optimization.
 
The new software simplifies and speeds up the generation and transformation of raw label-free interaction data into high-quality information, reducing the time needed for screening and hit validation. Versatile, easy-to-use wizards guide assay set up, and options are available for designing custom assays, making Biacore T200 ideal for a multi-user environment.
 
The new software encompasses algorithms for efficient ranking and qualification of binders versus non-binders, and enables comparison of datasets through normalization of sample responses by a number of means. By performing detailed evaluation of a single sample or co-evaluating up to 5000 single-concentration samples from multiple runs with the same ease, Biacore™ T200 Software v.2.0 significantly reduces the time required for evaluation of large lead series.
 
For further information please visit www.gelifesciences.com/BiacoreT200software
*Trademark of GE Healthcare companies

FOLLOW US ON TWITTER

 

 





Subscribe

Subscribe



Newsbrief

Twitter Icon © Setform Limited
subscribe